As the White House and the US Congress continue to lock horns over President Donald Trump's proposed budget, scientists are…
Super UserJuly 28, 2017
GlaxoSmithKline will cut more than 30 drug development programmes and may sell its rare diseases unit, as the FTSE 100…
Super UserJuly 28, 2017
The day after emocha® Mobile Health, Inc., launched in 2013, CEO Sebastian Seiguer (pronounced SAY-ger) heard about a 3-year-old tuberculosis…
Super UserJuly 28, 2017
No area is hotter or attracting more dollars in pharma than immuno-oncology–the idea of harnessing the immune system to fight…
Super UserJuly 28, 2017
Emergent BioSolutions Inc. (NYSE:EBS) today announced a licensing agreement with Valneva SE for global exclusive rights to Valneva's Zika vaccine…
Super UserJuly 28, 2017
IonQ, an early-stage company developing quantum computing for commercial applications, today announced completion of a $20 million series B round…
Super UserJuly 28, 2017
A new type of trial design can help the healthcare industry bring beneficial therapies to patients sooner and stop researching…
Super UserJuly 28, 2017
Calling All Medical Device Innovators! We are now accepting proposals for our annual $250K pediatric medical device pitch competition. Up…
Super UserJuly 28, 2017
About the Cluster Action Plan TOHealth! brought together diverse participants from Human Health and Sciences ecosystem in the Toronto region…
Super UserJuly 28, 2017